CALLIPER Trial for Progressive MS Enrolls First Patient & The Benefits of Sun Exposure

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how Immunic Therapeutics has enrolled a patient in the Phase 2 clinical trial CALLIPER, testing oral IMU-838 for progressive MS; and reads the column by Ed Tobias, MS Wire, “Sun-seeking Finds Support in New Study.”

===================================

Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/

=====================================

To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/